ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $134,000 | -87.3% | 65,638 | -82.1% | 0.00% | -83.3% |
| Q3 2019 | $1,051,000 | -72.0% | 366,108 | -25.2% | 0.01% | -70.0% |
| Q2 2019 | $3,753,000 | +2.7% | 489,329 | +77.9% | 0.02% | 0.0% |
| Q1 2019 | $3,656,000 | +650.7% | 275,102 | +779.7% | 0.02% | +566.7% |
| Q4 2018 | $487,000 | +23.9% | 31,274 | +56.2% | 0.00% | +50.0% |
| Q3 2018 | $393,000 | -0.5% | 20,024 | +45.4% | 0.00% | 0.0% |
| Q2 2018 | $395,000 | +21.2% | 13,774 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $326,000 | -18.7% | 13,774 | -26.4% | 0.00% | 0.0% |
| Q4 2017 | $401,000 | – | 18,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |